Media Partners

Media Partners

Take a look at the media partners who have decided to support this year's 2nd Annual mRNA-Based Therapeutics Summit. Get in touch if you would like to partner and connect with professionals in the mRNA field.

Gene Therapy Net

Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network for the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines.

www.genetherapynet.com

PJ-Logo

Pharma Journalist

Pharma Journalist provides the latest news, articles, whitepapers, press releases, case studies, interviews, projects, events to pharma industry decision-makers.

www.pharmajournalist.com

Cell-Gene-logo

Cell & Gene 

The landscape of the life sciences industry is as vast and varied as the professionals who work in it. Some online resources aim to serve the entire space. We wish them luck. Instead, our goal is to be the most valuable resource for a specific segment of the industry – cell & gene therapies – and the professionals who make their living there. The Cell & Gene community is not made up of generalists. They’re specialists, like us. We deliver in-depth content from authoritative authors and sources because that’s what our community demands.

e-book

RNA's Potential Impact for Modern Medicine

Erin Harris
Editor-In-Chief

Cell & Gene

mRNA e-book
Print

Pharmaphorum 

pharmaphorum uses content to connect the pharmaceutical industry and other innovators to advance healthcare, leveraging its own global publications and delivering direct content marketing, medical and communications services to clients in the healthcare sector. pharmaphorum.com, and its associated digital magazine Deep Dive, is a leading online destination for healthcare and pharmaceutical industry news, insight and debate.

download (2)

Fierce Biotech

Providing end-to-end coverage of biotech and medtech, from pre-clinical science through clinical testing and regulatory approval—and all the seed funding, venture capital, licensing deals, IPOs and M&A that happen along the way.